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at 24hours.
N (pts) 500
Timeplaoement(mh.) 5.6k 4
Manualpreseureues(%) 18
Compression>30 min.(%) 2
Hematoma(ailsize)(%) 5
Falseaneurysm(%) 1.6
Tmnsfusion(%) 1.2
Va.mularsurgew(%) 1.5
300
1,1 & 2 <0,001
25 <0,05
6 -=0.01
8 NS
2.5 NS
1.6 NS
2 NS
Thus, PAS has a slightly higher rate of immediate hemosteais than PAA,
with a more time-consuming placement. complication rate are Similady IOW
in both groups.
I 108O-18I Europ@*nFr-domStentRe*istV
l.K. De Soheerder, B. Chevalier, C. Va!$SaW. UWWSI!YHOSPMS,LeUVen,
Belgium
The Freedom’” stent (Globai Therapeutics, Inc.) isa new balloon expandable
coronary stent based on a high biocompatibilify 0.18 mm 316LVM stainleas
stwl wire, folded in bendad concentric loops, enabiing batter vessel align-
ment. Between November 1984 and August 1996, 1630 pts with 1726 lesions
were treated with 1923 stems In 16 centres. In 402 pte (24.7%) stents were
implanted as a bail-out procedur?, in 724 pte (44.4%) for optimalisation of a
suboptimal PTCA result, in 91 pts (5.6%) for treatment of recurrent resteno-
sis, and finaily in 413 pte (25.3%) as an elective procedure.
Anglographic success waeobtained in 15S1pts (97%). In-hoapitalcompli-
cations occurred in 72 pte (4.4%). Acute stent closure (-=24 h) n = 13 (0.8%),
subacute atent closure n = 7 (0.4%), AMi n = 12 (0.7%), emergency CABG
n = 13 (0.8%), death n = 5 (0.3’7.), major local complications n = 22 (1.3%).
Recurrence of angina pecforis anctlor a positive stress test during follow-up
occurred in 89 pts (5.47.). Systematic elective 6 m angiographlc follow-up
was performed in two Centres (n = 158 pts). Restenosis rSte (Z 50% DS)
was 26.8%, quantitative coronary analysls: minimal Iuminal diameter before
stenting: 1.01 + 0.93 mm, after stenting: 2.82 + 0.52 mm, at follow-up: 1.S8
+ 0.80 mm.
In conclusion: The Fraadom@intrecofonary stent can be placed suc-
cessfully in the majority of pts with a high rate of anglographic succass.
In-hospital complication rates were rare usin9 a Ticlopidin-AsPifin Prot.c.l.
Clinical follow-up wee favorable and the quantitative coronary analysis in
these non-selected coronaIy lesions revealad a restenosis rate of 26.6%.
C3108031 FrenchFreedomStentRegietry:MidtermReeulta
B. Chevalier, P. Montserrat, R. Huguet, P.Commaau, B. Lmcelin,
P.Dupouy, Y. Lienhart, L. Caster, O. Wittenberg, O. Tavolaro. Centre
Cardiologiqua du Nerd, Clinique Saint-Augustin, Saint-Denis, Bordeaux,
France
Thesafetyand efficeCyOfa newcoronary eoilatairleasateel atent (Freedomw)
wee aasessad by a retrospective atudy of consecutive early experiencaacoi-
Iected in 19 french centers. From 03/95 to OtYS8,1337 pts (18% women,
age: 62 +- 11y.) were treated on 1452 Iesiona using 1550 Freedom stems.
Artery diameter was 3.3 +– 0.5 mm; lesion was: A type 10Yo;B type 80?4.,C
type 30%. Lesion length was 15 +– 10 mm. Stent indication were: de novo
37%, restenosis 8%, sub-optimal resuit with dissection 38%, recoil 18% and
bail-out 3%. A 6 F sheath wee placed in 80% of oases; all pts received a
ticlopidinehzepirin drug regimen. Aftar infiation at 10.8 +- 2.4 atm. of a 3.4
+- 0.28 mm balloon to deploy the stent, final minimal Iuminal diameter was
3.1 +- 0.5 mm. Technical success was noted in 95.2%. Acute thrombcais (<
24 h) was noted in 1.1% and sub-acute thrombosis in 0.9%. Clinical success
rate was 88%; adverse eVentawere: Ml 1.5%, emergent CABG 0.7%, death
0.9% (inciuding acute Mi PTCA). Majof iocal mmplieetion rate was 1.6Y0.
In the first 470 pts, six months tafget late revaecularieation (TLR) rate was
11.5%. Predictive factors of TLR were: artery diameter -=2.5 mm, residual
stenosis > 20% and stent iength >25 mm.
Thua, in thia large multicenter registv, short and midterm reaults of Free-
dom stent implantation in mmplex ooronaty Ieaionsare satisfactory.
m108032 AreRandomizedTrialaNeceeeerytoAssessLong-TermOutcomewithNewDevicesfor
CoronaryIntervention?
D.L. Fischman, M.P. Savage, J. Brinker, C.J. Pepina, S. King, E. Topol,
R. Rake, D. Rehmann, S. Goldberg. Jefferson Medical College,
Philadelphia, PA, USA
Nonrandomized registries have provided obsawational data with respect to
Palmez-Schafz stent use in the treatment of atherosclerotic diaeaae in both
native coronary arteries and saphenous vein bypass grafts (SVG). There ie
increased pressure to utilize registry data in Iiau .of randomized trial data
due to logistic and economic concerns. The purpose of this analysis was to
compare restenosis ratas from tha JJIS stent regiatrles with randomized trials
STRESS (STent REStenosia Study) and SAVED (SAphenous VEin Denovo
triai). Similar inclusion and exclusion criteria, implantation technique, and
anticoagulation regimen were used In the regisby cohorts and corresponding
randomized trial. Quantitative angiographic analyses were performed by the
same core laboratory forall studies.Theresult6aresummarizedbeiow:
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Thus, a significant discordance in restenosis rates was obsewed be-
tween registry and randomized studies despite similar inclusion criteria and
angiographic anaiysis by the same core laboratoV. These findings suggest
a bias In obsewatlonal registries predisposing toward favorable outcomes.
Prospective randomized trials are neeessay to assess the true efficacy of
new interventional devices.
-] AreSTRESSResul* Generaliable?The
NACI-PSSExperience
C.J. George, E.D. Kennard, R. Holubkov, K.M. Detfe. Univera/fy of
Piftsbugh, Pittsburgh, PA, USA
Of 522 NACi registry patiants receiving elective Palmatz-Schatz coronay
stents (PSS), 485 (93%) were STRESS ineligible (IPss),and 34 (7%) were
STRESSeiigible(EpS6).One yeaf events (lPSSvs. EPSS) were:DM = death
or myocardial infarction (14% vs. 8%), TLR = targat lesion revascuiarization
(22% vs. 9%), and D/MilTLR (31% VS.15%, p < 0.05). Adjustad reiative tisks
of one year events by presence of ineligibility criteria were as followe:
IneligibilityCriteria: % Prevalence DIMI Events Di?..tl/TLR
in NACI-PSS TLR
Poor EF (<35°,6) 4 1.8 1.1 t.3
Left Main Disease s 2.3** 1,6 2.2**
Ml <1 Week Prior 5 1.3 1,4 1.3
Restenotk Lesion 5s 0.7 1.5 1.2
Graft Vessel 44 1.5 0.8 1.1
Small RV (< 2.f mm) 3 f.1 0.8
LongLeaion(> 15 mm) 5 1.s 2.3* 2.6”*
LowStenosis(<55°/9) 6 1.6 1.0 1.1
Thrombus 6 1.9 1.1 1.8*
Tortuosify 3 1.3 1.4 1.2
DiffuseLesion 21 1.3 1.1 1.3
Ostial Leaion 2 2.3 3.3* 2.s”
EF = EjactionFraction,RV = Referancevessel, *p <0.05, **p <0.01
Conclusion: STRESS fesults may not generalize to the maj6rity of NACl-
PSS patients, especially those with left main disease, long lesions, lesions
with thrombus, or ostial lesions.
m108034 EvolvingTrendsinAngioplastyDeviceSelection:A NationalCardiovascularNetwork(NCN)
DatabaeaReport
E.D. Peteraon, A.J. Lansky, L.H. Muhlbaier, M.B. Leon, L. Navey,
M.J. Lenzilotta, J.J. Popma, L.F. Satler. Duke LAriversifyMedica/ Center,
Durham, NC, USA
Recent new device angioptasfy trials assessing the late clinical outcomes af-
ter stents, directional athefectomy (DCA), and rotational athefectomy (RA),
may influence intetventional operator strategies. To characterize these po-
tential effects, we reviewed serial trends in stent, DCA, and RA use between
1/94 and 12/95, using the NCN 41,684 patient dstabase from 18 nationwide
high-volume interventional centers. Serial trends are shown below (Figure&
Table),
